Omezyl (Omeprazole)

Omeprazole, the active ingredient in Omezyl, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and Zollinger‑Ellison syndrome in adults and adolescents. GNH USA supplies Omezyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omezyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omezyl is a proton‑pump inhibitor that acts on the gastric acid secretion pathway.

- Gastro‑oesophageal reflux disease: Provides symptomatic relief and promotes healing of erosive esophagitis. - Peptic ulcer disease: Facilitates ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: Controls excessive gastric acid secretion associated with gastrin‑producing tumours. - NSAID‑induced gastropathy: Helps prevent ulcer formation in patients requiring long‑term NSAID therapy. - H‑